Ramamurthy Gopalakrishnan - Infectious Diseases

Author Information

Ramamurthy Gopalakrishnan is affiliated with the Institute of Infectious Diseases at Apollo Hospitals in Chennai, India. His work is primarily focused on infectious diseases, contributing significantly to the understanding and management of these conditions through his research and clinical practice.

Research Contributions

Ramamurthy Gopalakrishnan has made substantial contributions to the field of infectious diseases, with a particular interest in hospital-acquired infections, COVID-19, and various bacterial and fungal infections. His research includes prospective surveillance studies, clinical profiles of invasive infections in non-neutropenic patients, and the significance of laboratory markers in predicting outcomes in diseases such as COVID-19. His work has also covered case reports and series that shed light on uncommon but treatable infectious diseases like melioidosis.

Aliases

Ramamurthy Gopalakrishnan is also known by other names such as R Gopalakrishnan, R. Gopalakrishnan, and Ram Gopalakrishnan. These aliases are used across different publications and databases.

Publication and Citation Metrics

Citation Count	1030
H-index	15
Paper Count	100

Publications:

FIVE YEARS TREND OF DEVICE ASSOCIATED HOSPITAL-ACQUIRED INFECTIONS IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA-A PROSPECTIVE SURVEILLANCE STUDY.

DOI: 10.36106/ijsr/4100175

Year: 2022

Infections caused by Aeromonas species in hospitalized patients: A case series.

DOI: 10.1016/j.ijmmb.2022.01.006

Year: 2022

Fungal abscess after intra-orbital steroid injection: a case report.

DOI: 10.1080/01676830.2021.1903043

Year: 2021

Clinical Profile of Non-neutropenic Patients with Invasive Candidiasis: A Retrospective Study in a Tertiary Care Center

DOI: 10.5005/jp-journals-10071-23748

Year: 2021

Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable

DOI: 10.5005/jp-journals-10071-23749

Year: 2021

Significance of RDW in predicting mortality in COVID‐19—An analysis of 622 cases

DOI: 10.1111/ijlh.13526

Year: 2021

Avifavir in Treating Patients with Moderate Covid 19

DOI: 10.1093/cid/ciaa1601

Year: 2020

Streptococcus dysgalactiae septic arthritis of sternoclavicular joint with bacteraemia

DOI: 10.4103/ijmm.IJMM_20_257

Year: 2020

Streptococcus dysgalactiae Septic Arthritis of Sternoclavicular Joint with Bacteraemia.

DOI: 10.4103/ijmm.IJMM_20_257

Year: 2020

D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases

DOI: 10.1016/j.dsx.2020.11.007

Year: 2020

What are Commonly Used ACTs?

What Causes Respiratory Symptoms in Infectious Diseases?

How to Use Antibiotics Responsibly?

How Do Fungi Infect Hosts?

What is the Future of Genomic Sequencing in Infectious Diseases?

What are CRISPR-Cas Systems?

How Do Vaccines Work?

What is Malaria?

How Do Pathogens Spread?

How Common is Salmonella?

Partnered Content Networks

Relevant Topics